Analyst Reco. BrainsWay Ltd. Nasdaq

Equities

BWAY

US10501L1061

Real-time Estimate Cboe BZX Other stock markets 09:25:44 10/06/2024 pm IST			5-day change	1st Jan Change
6.51 ^USD	+1.09%		-1.81%	+0.31%

03/06	Brainsway's Deep Transcranial Magnetic Stimulation Gets Expanded FDA Labeling; Shares Rise	MT
03/06	BrainsWay Ltd. Receives Expanded FDA Labeling to Treat Late Life Depression	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	09/05	MT
HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	09/05	MT
Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating	16/11	MT
Raymond James Downgrades Brainsway to Market Perform From Outperform	16/11	MT
BRAINSWAY : HC Wainwright Adjusts Brainsway's Price Target to $14 from $17, Keeps Buy Rating	12/21/12	MT
BRAINSWAY : HC Wainwright Initiates Brainsway at Buy Rating With $17 Price Target	19/21/19	MT
BRAINSWAY : Oppenheimer Adjusts Brainsway PT to $15 From $13 on Q4 Results & New Opportunities, Maintains Outperform Rating	26/21/26	MT
BRAINSWAY : Raymond James Adjusts Brainsway's Price Target to $12 From $9, Keeps Outperform Rating	17/21/17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer